Show simple item record

dc.contributor.authorGniado, Katarzyna
dc.contributor.authorLöbmann, Korbinian
dc.contributor.authorRades, Thomas
dc.contributor.authorErxleben, Andrea
dc.date.accessioned2017-05-23T13:55:58Z
dc.date.available2017-05-23T13:55:58Z
dc.date.issued2016-03-16
dc.identifier.citationGniado, Katarzyna, Löbmann, Korbinian, Rades, Thomas, & Erxleben, Andrea. (2016). The influence of co-formers on the dissolution rates of co-amorphous sulfamerazine/excipient systems. International Journal of Pharmaceutics, 504(1–2), 20-26. doi: https://doi.org/10.1016/j.ijpharm.2016.03.023en_IE
dc.identifier.issn1873-3476
dc.identifier.urihttp://hdl.handle.net/10379/6538
dc.description.abstractA comprehensive study on the dissolution properties of three co-amorphous sulfamerazine/excipient systems, namely sulfamerazine/deoxycholic acid, sulfamerazine/citric acid and sulfamerazine/sodium taurocholate (SMZ/DA, SMZ/CA and SMZ/NaTC; 1:1 molar ratio), is reported. While all three co-formers stabilize the amorphous state during storage, only co-amorphization with NaTC provides a dissolution advantage over crystalline SMZ and the reasons for this were analyzed. In the case of SMZ/DA extensive gelation of DA protects the amorphous phase from crystallization upon contact with buffer, but at the same time prevents the release of SMZ into solution. Disk dissolution studies showed an improved dissolution behavior of SMZ/CA compared to crystalline SMZ. However, enhanced dissolution properties were not seen in powder dissolution testing due to poor dispersibility. Co-amorphization of SMZ and NaTC resulted in a significant increase in dissolution rate, both in powder and disk dissolution studies. (C) 2016 Elsevier B.V. All rights reserved.en_IE
dc.description.sponsorshipThis work was supported by Science Foundation Ireland under Grant No. [07/SRC/B1158] as part of the Synthesis and Solid State Pharmaceutical Centre (SSPC).en_IE
dc.formatapplication/pdfen_IE
dc.language.isoenen_IE
dc.publisherElsevieren_IE
dc.relation.ispartofInternational Journal Of Pharmaceuticsen
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectCo-amorphizationen_IE
dc.subjectDissolution studiesen_IE
dc.subjectDispersibilityen_IE
dc.subjectSulfamerazineen_IE
dc.titleThe influence of co-formers on the dissolution rates of co-amorphous sulfamerazine/excipient systemsen_IE
dc.typeArticleen_IE
dc.date.updated2017-05-18T08:09:34Z
dc.identifier.doi10.1016/j.ijpharm.2016.03.023
dc.local.publishedsourcehttps://doi.org/10.1016/j.ijpharm.2016.03.023en_IE
dc.description.peer-reviewedpeer-reviewed
dc.contributor.funder|~|
dc.internal.rssid11047578
dc.local.contactAndrea Erxleben, School Of Chemistry, Room 150, Arts/Science Building, Nui Galway. 2483 Email: andrea.erxleben@nuigalway.ie
dc.local.copyrightcheckedNo
dc.local.versionACCEPTED
nui.item.downloads486


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland